Company Name: |
ShangHai Biochempartner Co.,Ltd
|
Tel: |
17754423994 17754423994 |
Email: |
2853530910@QQ.com |
Products Intro: |
Product Name:Emibetuzumab CAS:1365287-97-3 Purity:95% Package:100ug;500ug;1mg
|
Company Name: |
Guangzhou Hongyuan Chemical Co.,Ltd
|
Tel: |
15817493340 |
Email: |
981810490@qq.com |
Products Intro: |
Product Name:Emibetuzumab CAS:1365287-97-3 Purity:95% Package:1mg;1g;100g
|
Company Name: |
Wuhan Chemstan Biotechnology Co., Ltd.
|
Tel: |
027-65317797 15926423062 |
Email: |
422450190@qq.com |
Products Intro: |
Product Name:Emibetuzumab Purity:>95%;1mg/ml Package:200ug;500ug;1mg
|
Company Name: |
AntibodySystem
|
Tel: |
17762345272 18162686757 |
Email: |
biolab-reagents@atagenix.com |
Products Intro: |
Product Name:Research Grade Emibetuzumab(DHC34201) CAS:1365287-97-3 Purity:PAGE:>95% Package:100ug;1mg
|
|
| Emibetuzumab Basic information |
Product Name: | Emibetuzumab | Synonyms: | Emibetuzumab;Research Grade Emibetuzumab(DHC34201);Emibetuzumab (anti-MET);LY2875358 | CAS: | 1365287-97-3 | MF: | | MW: | 0 | EINECS: | | Product Categories: | | Mol File: | Mol File | ![Emibetuzumab Structure]() |
| Emibetuzumab Chemical Properties |
form | Liquid | color | Colorless to light yellow |
| Emibetuzumab Usage And Synthesis |
Description | Emibetuzumab is a bivalent antibody that blocks HGF- and MET-receptor interaction,
leading to MET internalization and degradation. | Clinical Use | A phase I study determined a tolerable dose for emibetuzumab to be 700–2000 mg as a monotherapy and
in combination with erlotinib in NSCLC patients. It is currently being investigated in phase II in combination with erlotinib. |
| Emibetuzumab Preparation Products And Raw materials |
|